Showing results (61-70 of 97) with videos related to
Sort By:
Pageof 10
Journal of Pharmaceutical Health Care and Sciences|June 9, 2018
Changes in the quality of medicines during storage under LED lighting and consideration of countermeasuresShuuji Yamashita, Kazuhiro Iguchi, Yoshihiro Noguchi, et al.Cureus|October 1, 2024
Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing MapKoumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, et al.Journal of Nutritional Science and Vitaminology|June 9, 2015
Anti-Androgenic Activity of Icarisid II from Epimedium Herb in Prostate Cancer LNCaP CellsYoko Miura, Masayoshi Oyama, Kazuhiro Iguchi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 16, 2017
[Body Surface Area Formulas for the Calculation of the Chemotherapy Dosage]Haruna Hatahira, Kazuhiro Iguchi, Sayaka Sasaoka, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 3, 2020
[Survey of Label Information of Foods with Function Claims]Miho Mori, Akari Shimauchi, Satoko Yajima, et al.Plos One|May 29, 2026
Spatial analysis of accessibility to healthcare-related facilities in Tokyo Metropolis using geographic information systemsTomofumi Yamazaki, Seiichiro Ito, Yoko Ino, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 28, 2017
Study on Students' Impression Data in Practical Training Using Text Mining Method-Analysis of Considerable CommunicationHitomi Teramachi, Ikuto Sugita, Yoko Ino, et al.Currents in Pharmacy Teaching & Learning|May 26, 2018
Evaluating communication skills after long-term practical training among Japanese pharmacy studentsHitomi Teramachi, Yoko Ino, Ikuto Sugita, et al.Chemico-Biological Interactions|July 16, 2016
Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanismToshiyuki Matsunaga, Ayaka Suzuki, Chihiro Kezuka, et al.SAGE Open Medicine|May 31, 2018
Adverse events of smoking cessation treatments (nicotine replacement therapy and non-nicotine prescription medication) and electronic cigarettes in the Food and Drug Administration Adverse Event Reporting System, 2004-2016Yumi Motooka, Toshinobu Matsui, Rachel M Slaton, et al.Pageof 10